Sangamo Therapeutics (SGMO) Short Interest Ratio & Short Volume → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free SGMO Stock Alerts $0.57 -0.05 (-8.01%) (As of 05/29/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Sangamo Therapeutics Short Interest DataCurrent Short Interest14,730,000 sharesPrevious Short Interest14,360,000 sharesChange Vs. Previous Month+2.58%Dollar Volume Sold Short$8.54 millionShort Interest Ratio7.4 Days to CoverLast Record DateMay 15, 2024Outstanding Shares207,510,000 sharesPercentage of Shares Shorted7.10%Today's Trading Volume1,576,163 sharesAverage Trading Volume2,066,644 sharesToday's Volume Vs. Average76% Short Selling Sangamo Therapeutics ? Sign up to receive the latest short interest report for Sangamo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSGMO Short Interest Over TimeSGMO Days to Cover Over TimeSGMO Percentage of Float Shorted Over Time Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Sangamo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202414,730,000 shares $8.54 million +2.6%N/A7.4 $0.58 4/30/202414,360,000 shares $7.39 million +8.4%N/A6.2 $0.51 4/15/202413,250,000 shares $7.36 million +16.1%N/A5.6 $0.56 3/31/202411,410,000 shares $7.65 million +4.9%N/A4.9 $0.67 3/15/202410,880,000 shares $8.49 million +8.2%N/A4.6 $0.78 2/29/202410,060,000 shares $11.67 million +3.4%N/A4.7 $1.16 Get the Latest News and Ratings for SGMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sangamo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20249,730,000 shares $10.22 million -2.5%N/A4.8 $1.05 1/31/20249,980,000 shares $4.56 million +9.0%N/A6 $0.46 1/15/20249,160,000 shares $4.72 million +0.2%N/A5.5 $0.52 12/31/20239,140,000 shares $4.97 million -0.8%N/A4.9 $0.54 12/15/20239,210,000 shares $3.82 million -4.9%N/A4.3 $0.42 11/30/20239,680,000 shares $4.16 million -6.1%N/A4.7 $0.43 11/15/202310,310,000 shares $3.77 million -11.0%N/A4.9 $0.37 10/31/202311,590,000 shares $7.30 million +10.4%N/A6.1 $0.63 10/15/202310,500,000 shares $5.88 million +15.3%N/A5.9 $0.56 9/30/20239,110,000 shares $5.46 million -5.2%N/A4.9 $0.60 9/15/20239,610,000 shares $9.60 million -8.1%N/A6.3 $1.00 8/31/202310,460,000 shares $10.14 million -2.5%N/A5.5 $0.97 8/15/202310,730,000 shares $10.84 million -1.5%N/A5.1 $1.01 7/31/202310,890,000 shares $14.32 million -5.2%N/A4.7 $1.32 7/15/202311,490,000 shares $14.82 million -4.0%N/A4.6 $1.29 6/30/202311,970,000 shares $15.56 million -19.2%N/A4.7 $1.30 6/15/202314,820,000 shares $17.19 million +1.9%N/A5.6 $1.16 5/31/202314,540,000 shares $16.28 million -17.4%N/A6.3 $1.12 5/15/202317,610,000 shares $23.60 million -12.9%N/A7.5 $1.34 4/30/202320,220,000 shares $29.72 million +3.8%14.1%9.5 $1.47 4/15/202319,490,000 shares $32.16 million +4.4%13.6%10 $1.65 3/31/202318,670,000 shares $32.86 million +13.8%14.2%10.5 $1.76 3/15/202316,410,000 shares $35.45 million +38.1%12.5%10.1 $2.16 2/28/202311,880,000 shares $36.23 million +2.2%9.0%7.8 $3.05 2/15/202311,620,000 shares $34.86 million -2.5%9.1%8.6 $3.00 1/31/202311,920,000 shares $41.60 million -0.8%9.3%8.8 $3.49 1/15/202312,010,000 shares $43.72 million -2.8%9.4%8.7 $3.64 12/30/202212,360,000 shares $38.81 million +11.0%9.6%9 $3.14 12/15/202211,140,000 shares $36.76 million -1.2%8.7%8.1 $3.30 11/30/202211,270,000 shares $41.25 million -0.7%8.9%8.3 $3.66 11/15/202211,350,000 shares $44.38 million -6.5%9.0%8 $3.91 10/31/202212,140,000 shares $53.29 million +1.3%8.8%8.4 $4.39 10/15/202211,980,000 shares $55.47 million +9.4%9.1%8.3 $4.63 9/30/202210,950,000 shares $53.66 million +17.5%8.3%7.4 $4.90Biden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. 9/15/20229,320,000 shares $54.06 million +5.6%7.1%6.1 $5.80 8/31/20228,830,000 shares $47.68 million -6.8%6.8%5.5 $5.40 8/15/20229,470,000 shares $60.51 million -4.9%7.3%5.6 $6.39 7/31/20229,960,000 shares $42.73 million -3.5%8.2%5.6 $4.29 7/15/202210,320,000 shares $46.85 million -3.0%8.5%5.9 $4.54 6/30/202210,640,000 shares $44.05 million +1.3%8.8%6.2 $4.14 6/15/202210,500,000 shares $36.23 million +4.9%10.3%6.2 $3.45 5/31/202210,010,000 shares $36.54 million +16.9%8.2%6.7 $3.65 5/15/20228,560,000 shares $34.41 million +6.2%7.0%6.1 $4.02 4/30/20228,060,000 shares $33.45 million +2.8%6.6%6.4 $4.15 4/15/20227,840,000 shares $41.24 million +2.8%6.5%6.4 $5.26 3/31/20227,630,000 shares $44.33 million +8.7%6.3%5.8 $5.81 3/15/20227,020,000 shares $36.78 million -3.7%5.8%5.2 $5.24 2/28/20227,290,000 shares $42.65 million -15.2%6.0%5.2 $5.85 2/15/20228,600,000 shares $51.60 million +2.1%7.1%5.9 $6.00 1/31/20228,420,000 shares $50.77 million -4.0%7.0%6 $6.03 1/15/20228,770,000 shares $56.13 million -1.9%7.3%5.7 $6.40 12/31/20218,940,000 shares $67.05 million -1.3%7.4%6.3 $7.50 12/15/20219,060,000 shares $70.22 million -13.8%7.5%6.9 $7.75 11/30/202110,510,000 shares $87.13 million +1.6%8.7%8.8 $8.29 11/15/202110,350,000 shares $101.64 million +2.2%8.6%9 $9.82 10/29/202110,130,000 shares $82.26 million -0.7%8.4%9.4 $8.12 10/15/202110,200,000 shares $89.25 million -2.5%8.5%12 $8.75 9/30/202110,460,000 shares $94.24 million -2.2%8.7%12 $9.01 9/15/202110,690,000 shares $97.92 million -6.3%8.9%11.3 $9.16 8/31/202111,410,000 shares $113.07 million -3.5%9.5%11.9 $9.91 8/13/202111,820,000 shares $118.79 million -1.3%9.8%12.9 $10.05 7/30/202111,980,000 shares $114.77 million -3.0%10.0%12.9 $9.58 7/15/202112,350,000 shares $121.40 million +4.5%10.4%12.7 $9.83 6/30/202111,820,000 shares $141.49 million -13.9%9.9%11.9 $11.97 6/15/202113,730,000 shares $154.74 million -5.2%11.5%13.7 $11.27 5/28/202114,480,000 shares $156.09 million -4.4%12.2%13.3 $10.78 5/14/202115,150,000 shares $157.56 million -0.2%N/A12.3 $10.40 4/30/202115,180,000 shares $180.64 million -5.3%N/A11.2 $11.90 4/15/202116,030,000 shares $186.59 million -3.0%N/A11.1 $11.64 3/31/202116,520,000 shares $192.79 million -0.2%N/A10.8 $11.67 3/15/202116,560,000 shares $191.10 million +6.0%N/A8.8 $11.54 2/26/202115,620,000 shares $174.79 million +0.4%N/A6.6 $11.19 2/12/202115,560,000 shares $215.66 million -0.7%N/A6.7 $13.86 1/29/202115,670,000 shares $222.36 million -6.6%N/A6.6 $14.19 1/15/202116,770,000 shares $271.51 million -2.5%N/A7.1 $16.19 12/31/202017,200,000 shares $289.99 million -1.6%N/A7.4 $16.86 12/15/202017,470,000 shares $228.51 million -13.4%N/A7.9 $13.08 11/30/202020,180,000 shares $204.22 million +4.0%N/A13.3 $10.12 11/15/202019,410,000 shares $222.83 million -4.7%N/A13 $11.48 10/30/202020,370,000 shares $216.13 million -3.4%N/A13.6 $10.61 10/15/202021,090,000 shares $237.47 million -1.2%N/A13.2 $11.26 9/30/202021,350,000 shares $201.76 million +9.1%N/A13.1 $9.45 9/15/202019,570,000 shares $208.81 million +4.4%N/A11.4 $10.67 8/31/202018,750,000 shares $206.81 million -3.1%N/A9.2 $11.03Biden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. 8/14/202019,340,000 shares $220.28 million +4.4%N/A9.2 $11.39 7/31/202018,520,000 shares $200.57 million -0.2%N/A8.2 $10.83 7/15/202018,550,000 shares $197.19 million -5.7%N/A8.5 $10.63 6/30/202019,660,000 shares $172.42 million +15.0%N/A8.6 $8.77 6/15/202017,100,000 shares $187.76 million +5.9%N/A7.3 $10.98 5/29/202016,150,000 shares $180.72 million -3.1%14.6%6.8 $11.19 5/15/202016,660,000 shares $167.27 million +2.8%15.0%6.1 $10.04 4/30/202016,210,000 shares $138.43 million -3.8%17.7%6.5 $8.54 4/15/202016,850,000 shares $122.67 million +1.8%18.4%6.9 $7.28 3/31/202016,560,000 shares $137.78 million 0.0%N/A6.9 $8.32 3/13/202016,566,600 shares $123.59 million -5.5%N/A4.2 $7.46 2/28/202017,530,000 shares $102.90 million -0.9%N/A8.2 $5.87 2/14/202017,680,000 shares $134.19 million -4.5%N/A10.6 $7.59 1/31/202018,510,000 shares $127.35 million +6.5%N/A11.2 $6.88 1/15/202017,380,000 shares $132.09 million +1.9%N/A10.8 $7.60 12/31/201917,050,000 shares $127.88 million +1.0%N/A11 $7.50 SGMO Short Interest - Frequently Asked Questions What is Sangamo Therapeutics' current short interest? Short interest is the volume of Sangamo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 14,730,000 shares of SGMO short. Learn More on Sangamo Therapeutics' current short interest. What is a good short interest ratio for Sangamo Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SGMO shares currently have a short interest ratio of 7.0. Learn More on Sangamo Therapeutics's short interest ratio. Is Sangamo Therapeutics' short interest increasing or decreasing? Sangamo Therapeutics saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 14,730,000 shares, an increase of 2.6% from the previous total of 14,360,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sangamo Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Sangamo Therapeutics: Curis, Inc. (1.11%), Agenus Inc. (15.73%), DBV Technologies S.A. (0.27%), Omega Therapeutics, Inc. (24.22%), Molecular Partners AG (0.14%), Vigil Neuroscience, Inc. (5.93%), aTyr Pharma, Inc. (0.50%), BioAtla, Inc. (10.81%), bluebird bio, Inc. (28.90%), Outlook Therapeutics, Inc. (8.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Sangamo Therapeutics stock? Short selling SGMO is an investing strategy that aims to generate trading profit from Sangamo Therapeutics as its price is falling. SGMO shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sangamo Therapeutics? A short squeeze for Sangamo Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SGMO, which in turn drives the price of the stock up even further. How often is Sangamo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SGMO, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Cellectis Short Interest bluebird bio Short Interest Atara Biotherapeutics Short Interest Adaptimmune Therapeutics Short Interest Lexicon Pharmaceuticals Short Interest Agenus Short Interest XOMA Short Interest Vanda Pharmaceuticals Short Interest Emergent BioSolutions Short Interest Codexis Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SGMO) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTradeThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyBUY ALERT: Tiny tech play partners with US governmentStansberry ResearchGold Set to EXPLODE!Gold Safe Exchange[Urgent!] Generational Wealth GameplanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sangamo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.